Identifying targets to mitigate immunotherapy-associated immune-related adverse events

Interrogating and targeting co-inhibitory and co-stimulatory molecules in CAR T-cell Therapies

Determining the role of neutrophils in anti-tumor immunity and immune-related adverse events in the context of T cell-based therapies

PICI Grant and Main Collaboration Agreement with Multiple Subprojects

Targeting VISTA on neutrophils to manage immunotherapy adverse events

VISTA-Positive Neutrophils in Melanoma Immunotherapy Skin Toxicities

Engineered IgA engagers to fight cancer

Sponsored Research Agreement - Merghoub Lab